Extra Virgin Olive Oil Boosts Brain Power Through the Gut Microbiome
A 2-year human study links extra virgin olive oil to better cognition and gut diversity — and identifies the specific microbes responsible.
Summary
A two-year study of 656 adults found that regularly consuming extra virgin olive oil improved cognitive performance and increased gut microbiota diversity compared to refined olive oil. Researchers from Universitat Rovira i Virgili tracked diet and gut bacteria in adults aged 55–75 with metabolic syndrome. Those using virgin olive oil showed better brain function over time, while refined oil users saw declining gut diversity. Scientists also pinpointed a specific gut bacterium — Adlercreutzia — potentially mediating these brain benefits. The findings suggest the polyphenols and antioxidants preserved in extra virgin olive oil, lost during refining, drive these effects through the gut-brain axis, making oil quality a meaningful dietary choice for aging adults.
Detailed Summary
Extra virgin olive oil has long been celebrated for heart and metabolic benefits, but new research suggests it may also protect the aging brain — and the gut microbiome appears to be the key mechanism. This is the first prospective human study to directly examine how olive oil type influences the gut-brain connection, making it a landmark finding in nutritional neuroscience.
The study, led by researchers at Universitat Rovira i Virgili and the Pere Virgili Health Research Institute, followed 656 adults aged 55–75 over two years. All participants were overweight or obese with metabolic syndrome — a population at elevated risk for cognitive decline. Conducted within the PREDIMED-Plus framework, the trial tracked olive oil consumption, gut microbiota composition, and cognitive performance at regular intervals.
Participants who regularly consumed virgin olive oil showed measurable improvements in cognitive function and maintained greater gut microbiota diversity — a widely accepted marker of metabolic and intestinal health. Those consuming refined olive oil experienced the opposite: declining microbiota diversity over the same period. Researchers identified Adlercreutzia, a specific genus of gut bacteria, as a potential mediating microbe linking olive oil quality to cognitive outcomes.
The distinction between oil types comes down to processing. Extra virgin olive oil is cold-pressed mechanically, preserving polyphenols, antioxidants, and bioactive compounds. Refining strips these away to improve shelf life and consistency. These lost compounds appear critical for feeding beneficial gut bacteria that, in turn, support brain health through the gut-brain axis.
For health-conscious adults, the practical implication is clear: not all olive oils are equal, and choosing certified extra virgin varieties may offer meaningful cognitive protection over time. Caveats include the study's focus on a high-risk metabolic population, meaning results may not generalize broadly. Replication in healthier cohorts and mechanistic studies are needed to confirm causality.
Key Findings
- Adults using extra virgin olive oil showed improved cognitive performance over 2 years vs. refined oil users.
- Refined olive oil consumption was linked to declining gut microbiota diversity over the study period.
- Gut bacterium Adlercreutzia was identified as a potential mediator of olive oil's brain-protective effects.
- Polyphenols and antioxidants — preserved in extra virgin but lost in refined oil — appear to drive gut-brain benefits.
- Choosing extra virgin over refined olive oil may be a simple, low-cost strategy to support brain aging.
Methodology
This is a research summary based on a peer-reviewed prospective cohort study from the PREDIMED-Plus project, a well-regarded Mediterranean diet trial. The source institution, Universitat Rovira i Virgili, is a credible European research university with an established Human Nutrition Unit. The two-year duration and 656-participant sample size lend reasonable statistical weight, though the article is a news summary and the full peer-reviewed paper should be consulted for effect sizes and methodology details.
Study Limitations
The study population was limited to overweight or obese adults with metabolic syndrome, which may limit generalizability to healthier individuals. As a prospective observational study, causality cannot be fully established — confounding dietary factors may play a role. The article is a news summary; readers should consult the primary publication for full statistical details, effect sizes, and microbiota methodology.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.